Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Priest

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Emerging Infectious Diseases|December 17, 2016
Loiasis in US Traveler Returning from Bioko Island, Equatorial Guinea, 2016David H Priest, Thomas B Nutman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Infectious disease images on the World Wide WebDavid H Priest, Stephen J Williams
Southern Medical Journal|October 13, 2005
Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: clinical features and therapeutic outcomesDavid H Priest, James E Peacock
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2019
Reply to McCreery et alSteven W Johnson, Shannon V Brown, David H Priest
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2019
Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic ExposureSteven W Johnson, Shannon V Brown, David H Priest
Clinical Liver Disease|January 29, 2024
Screening for hepatitis C as part of an opioid stewardship quality improvement initiative: Identifying infected patients and analyzing linkage to careRebekah B DeCamillis, Aliza L Hekman, David H Priest
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Use of intermittent rifampin and pyrazinamide therapy for latent tuberculosis infection in a targeted tuberculin testing programDavid H Priest, Louis F Vossel, Elizabeth A Sherfy, et al.
Idcases|June 27, 2018
Secondary immune thrombocytopenia (ITP) as an initial presentation of Whipple's diseaseDavid H Priest, Thomas H Grote, Sallie L Staley, et al.
Infection Control and Hospital Epidemiology|December 8, 2018
A regional collaboration between competing healthcare systems to establish influenza season parametersDavid H Priest, Susan L DeCamp-Freeze, Cynthia B Snider, et al.
International Journal of Antimicrobial Agents|April 9, 2017
Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approachSteven W Johnson, Shelby R Ammirati, Charles E Hartis, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Emerging Infectious Diseases|December 17, 2016
Loiasis in US Traveler Returning from Bioko Island, Equatorial Guinea, 2016David H Priest, Thomas B Nutman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Infectious disease images on the World Wide WebDavid H Priest, Stephen J Williams
Southern Medical Journal|October 13, 2005
Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: clinical features and therapeutic outcomesDavid H Priest, James E Peacock
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2019
Reply to McCreery et alSteven W Johnson, Shannon V Brown, David H Priest
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2019
Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic ExposureSteven W Johnson, Shannon V Brown, David H Priest
Clinical Liver Disease|January 29, 2024
Screening for hepatitis C as part of an opioid stewardship quality improvement initiative: Identifying infected patients and analyzing linkage to careRebekah B DeCamillis, Aliza L Hekman, David H Priest
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Use of intermittent rifampin and pyrazinamide therapy for latent tuberculosis infection in a targeted tuberculin testing programDavid H Priest, Louis F Vossel, Elizabeth A Sherfy, et al.
Idcases|June 27, 2018
Secondary immune thrombocytopenia (ITP) as an initial presentation of Whipple's diseaseDavid H Priest, Thomas H Grote, Sallie L Staley, et al.
Infection Control and Hospital Epidemiology|December 8, 2018
A regional collaboration between competing healthcare systems to establish influenza season parametersDavid H Priest, Susan L DeCamp-Freeze, Cynthia B Snider, et al.
International Journal of Antimicrobial Agents|April 9, 2017
Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approachSteven W Johnson, Shelby R Ammirati, Charles E Hartis, et al.
Pageof 2